Used as a selective antagonist for the chemokine receptor CXCR4, WRW4 TFA is employed in research to inhibit CXCR4-mediated signaling pathways. It helps in studying cell migration, cancer metastasis, and stem cell homing due to its ability to block the interaction between CXCR4 and its ligand, CXCL12. Commonly applied in immunological and oncological studies, it serves as a tool compound to probe receptor function in vitro and in animal models. Its trifluoroacetate salt form improves solubility and stability in biological assays.